300
Participants
Start Date
May 20, 2025
Primary Completion Date
May 20, 2027
Study Completion Date
May 20, 2030
Liquid Biopsy
Patients with metastatic breast cancer in disease progression will undergo a liquid biopsy
Archival Tumor DNA
Patients will be prompted to request an archival tumor sample from metastatic origin (preferably) and to send it to the central laboratory for analysis
RECRUITING
SOLTI Cancer Research Group, Barcelona
Collaborators (3)
Roche Farma, S.A
INDUSTRY
Menarini Group
INDUSTRY
AstraZeneca
INDUSTRY
Pfizer
INDUSTRY
Eli Lilly and Company
INDUSTRY
SOLTI Breast Cancer Research Group
OTHER